“Medicare Expands Access to Weight Loss Drugs as Popularity Surges” — what this page in the network covers. The utilization of GLP-1 medications for weight management is experiencing a significant surge across the United States. According to a recent Gallup poll, approximately 11% of American adults currently use these drugs, a sharp rise from only 3% reported two years ago. This trend is expected to continue growing as Medicare has officially opened the door for some beneficiaries to access these treatments through new discount programs.
William Brangham and Juliette Cubanski discuss the implications of this policy shift. As more patients gain financial access to these high-demand medications, the healthcare system faces new challenges in managing costs and distribution for a treatment that has quickly become a mainstream health solution for millions. The full version stays on the original page, which this listing opens directly.